About - Ercan Çalışkan
About Professor Dr. Ercan Çalışkan
Prof. Dr. Ercan Çalışkan completed his medical education at Gülhane Military Medical Faculty. He worked as a general practitioner in the Naval Forces for 3 years. After completing his specialist training in the Dermatology Department of the same faculty, he worked at the Dermatology Clinic of Gölcük Military Hospital. In 2011, he started teaching at the Dermatology Department of GATA Gülhane Medical Faculty and continued at the Health Sciences University after 2016. Since his retirement in 2025, he has been working as a Professor of Dermatology at Elos Klink.
In his clinical practice, he deals with chronic skin diseases such as psoriasis, hidradenitis suppurativa and vitiligo, as well as cosmetology, dermatological surgery and laser treatments. The practical training he gives in Turkey and abroad is mostly based on autologous fat and skin-based regenerative dermatological techniques. His scientific studies and publications continue largely with clinical studies and animal experiments on these subjects.
Scientific Publications
- Interruption versus continuation of adalimumab during hidradenitis surgery: secondary wound healing and postoperative complications. Esme P, Botsali A, Caliskan E. J Wound Care. 2025(2);34(2):112-118.
-
Autologous Fat Transplantation: Treating Chronic Fibrosis Caused by Doxorubicin Hydrochloride Extravasation on the Dorsum of the Hand. Çalişkan E, Doğan SN, Tuna A, Botsali A. Dermatol Surg. 2025 Jan 27. doi: 10.1097/DSS.0000000000004563.
- Dundar Yolsal O, Esme P, Karahan S, Tasci I, Caliskan E. Dermatol Surg. 2024 (1);50(11):1039-1045.
-
Development of a pig model of spontaneous pressure injury: A randomized self-controlled study. Bakcek Akcelik O, Ayhan H, Ali Aksoy O, Alp Goksel B, Caliskan E, Ceylan A, Ozgenc Cinar OJ Tissue Viability. 2024;33(2):284-291.
-
The Comparative Dermal Stimulation Potential of Constant-Volume and Constant-Amount Diluted Calcium Hydroxylapatite Injections Versus the Concentrated Form. Botsali A, Erbil H, Eşme P, Gamsızkan M, Aksoy AO, Caliskan E. Dermatol Surg. 2023 (1);49(9):871-876.
-
Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience. Esme P, Akoglu G, Dalkıran CD, Caliskan E. Dermatol Ther. 2022;35(11):e15782.
- An Anti-Interleukin-17A Monoclonal Antibody, Ixekizumab, in the Treatment of Resistant Hidradenitis Suppurativa: A Case Series. Esme P, Botsali A, Akoglu G, Caliskan E.Skin Appendage Disord. 2022;8(4):342-345.
-
Role of exosomes in skin diseases. Kose O, Botsali A, Caliskan E. J Cosmet Dermatol. 2022;21(8):3219-3225.
-
Combination of Full-Field and Fractional Erbium: YAG Laser for Nonhealing Wounds. Caliskan E, Botsali A. Lasers Med Sci. 2022;37(7):2823-2830.
Important Disclaimer
PlacidWay.com provides medical travel information, not healthcare services. We don't endorse any providers, and we're not responsible for the care you receive.
Pricing: Prices on our site are estimates only, provided by the centers. Always confirm actual prices directly with the provider before booking to ensure full transparency and avoid hidden fees.
Your Health: Consult your local licensed healthcare provider before pursuing any treatment found on our site. Your health decisions are your responsibility.
Share this listing